Explore

Events

March 22, 2023
Ann Neale at ICFSR

At the International Conference on Frailty and Sarcopenia Research in Toulouse, France, CDO Ann Neale presented data from BioAge's successful Phase 1 trial of our muscle aging drug BGE-105.
January 26, 2023
Kristen Fortney on Bio Eats World

CEO & co-founder Kristen Fortney joined Vijay Pande, founding partner of a16z Bio + Health, in a discussion spanning the biology of aging, BioAge’s mission to fight age-related disease…and how long a _hypothetical_ venture capitalist can expect to live.
January 21, 2023
Dr. Eric Morgen on the Talking Biotech podcast

COO & co-founder Eric Morgen talks about aging as a risk for chronic disease, and BioAge’s approach to developing therapeutics that might slow or prevent age-related disorders.
January 4, 2023
Virtual KOL event for apelin receptor agonist BGE-105

BioAge leadership described target discovery by our AI-driven platform, clinical development, and the positive data from our Phase 1b trial, and two world-leading experts explained the clinical importance of muscle aging and the acute myopathies to be addressed in Phase 2.

1445A South 50th Street, Richmond, CA 94804

1445A South 50th Street, Richmond, CA 94804

Ann Neale at ICFSR